The Future of CBD research, marketing, and regulation

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at Supplement Advisory Group, discuss Atlantia’s expertise in clinical trials for CBD.